Annual FCF
-$12.85 M
+$6.25 M+32.73%
31 December 2023
Summary:
Salarius Pharmaceuticals annual free cash flow is currently -$12.85 million, with the most recent change of +$6.25 million (+32.73%) on 31 December 2023. During the last 3 years, it has fallen by -$2.53 million (-24.55%). SLRX annual FCF is now -25.94% below its all-time high of -$10.20 million, reached on 31 December 2021.SLRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.36 M
-$284.50 K-26.53%
30 September 2024
Summary:
Salarius Pharmaceuticals quarterly free cash flow is currently -$1.36 million, with the most recent change of -$284.50 thousand (-26.53%) on 30 September 2024. Over the past year, it has increased by +$2.39 million (+63.81%). SLRX quarterly FCF is now -82.60% below its all-time high of -$743.00 thousand, reached on 30 June 2019.SLRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$5.29 M
+$2.39 M+31.12%
30 September 2024
Summary:
Salarius Pharmaceuticals TTM free cash flow is currently -$5.29 million, with the most recent change of +$2.39 million (+31.12%) on 30 September 2024. Over the past year, it has increased by +$10.75 million (+67.01%). SLRX TTM FCF is now -27.05% below its all-time high of -$4.17 million, reached on 31 March 2015.SLRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLRX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.7% | +63.8% | +67.0% |
| 3 y3 years | -24.6% | +14.2% | +40.2% |
| 5 y5 years | +45.6% | +75.5% | +56.2% |
SLRX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.9% | +32.7% | -26.5% | +76.4% | at high | +72.3% |
| 5 y | 5 years | -25.9% | +45.6% | -26.5% | +76.4% | at high | +72.3% |
| alltime | all time | -25.9% | +60.6% | -82.6% | +85.7% | -27.1% | +83.8% |
Salarius Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.36 M(+26.5%) | -$5.29 M(-31.1%) |
| June 2024 | - | -$1.07 M(-20.8%) | -$7.69 M(-30.3%) |
| Mar 2024 | - | -$1.35 M(-10.4%) | -$11.03 M(-14.1%) |
| Dec 2023 | -$12.85 M(-32.7%) | -$1.51 M(-59.7%) | -$12.85 M(-20.0%) |
| Sept 2023 | - | -$3.75 M(-15.1%) | -$16.05 M(-11.0%) |
| June 2023 | - | -$4.42 M(+39.3%) | -$18.04 M(+4.6%) |
| Mar 2023 | - | -$3.17 M(-32.8%) | -$17.24 M(-9.7%) |
| Dec 2022 | -$19.10 M(+87.2%) | -$4.71 M(-17.9%) | -$19.10 M(+11.7%) |
| Sept 2022 | - | -$5.74 M(+58.6%) | -$17.10 M(+32.1%) |
| June 2022 | - | -$3.62 M(-27.9%) | -$12.94 M(+3.6%) |
| Mar 2022 | - | -$5.02 M(+84.5%) | -$12.50 M(+22.5%) |
| Dec 2021 | -$10.20 M(-1.1%) | -$2.72 M(+72.0%) | -$10.20 M(+15.2%) |
| Sept 2021 | - | -$1.58 M(-50.2%) | -$8.85 M(-11.7%) |
| June 2021 | - | -$3.17 M(+16.6%) | -$10.02 M(+7.5%) |
| Mar 2021 | - | -$2.72 M(+98.2%) | -$9.33 M(-9.6%) |
| Dec 2020 | -$10.31 M(-10.9%) | -$1.37 M(-50.1%) | -$10.31 M(-10.9%) |
| Sept 2020 | - | -$2.75 M(+11.2%) | -$11.57 M(-19.4%) |
| June 2020 | - | -$2.48 M(-33.2%) | -$14.36 M(+13.7%) |
| Mar 2020 | - | -$3.71 M(+40.6%) | -$12.63 M(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$11.58 M(-50.9%) | -$2.64 M(-52.4%) | -$11.58 M(-4.1%) |
| Sept 2019 | - | -$5.54 M(+645.9%) | -$12.08 M(+29.4%) |
| June 2019 | - | -$743.00 K(-72.1%) | -$9.33 M(-44.6%) |
| Mar 2019 | - | -$2.66 M(-15.2%) | -$16.84 M(-28.6%) |
| Dec 2018 | -$23.60 M(-15.2%) | -$3.13 M(+12.1%) | -$23.60 M(-10.0%) |
| Sept 2018 | - | -$2.80 M(-66.1%) | -$26.23 M(-16.8%) |
| June 2018 | - | -$8.26 M(-12.3%) | -$31.53 M(+8.7%) |
| Mar 2018 | - | -$9.41 M(+63.1%) | -$29.00 M(+4.2%) |
| Dec 2017 | -$27.84 M(-14.6%) | -$5.77 M(-28.7%) | -$27.84 M(-2.0%) |
| Sept 2017 | - | -$8.10 M(+41.5%) | -$28.41 M(+2.2%) |
| June 2017 | - | -$5.72 M(-30.6%) | -$27.79 M(-12.0%) |
| Mar 2017 | - | -$8.25 M(+29.9%) | -$31.58 M(-3.2%) |
| Dec 2016 | -$32.61 M(+55.2%) | -$6.35 M(-15.0%) | -$32.61 M(+2.7%) |
| Sept 2016 | - | -$7.47 M(-21.4%) | -$31.74 M(+2.0%) |
| June 2016 | - | -$9.51 M(+2.5%) | -$31.12 M(+19.1%) |
| Mar 2016 | - | -$9.28 M(+69.4%) | -$26.13 M(+24.3%) |
| Dec 2015 | -$21.01 M | -$5.48 M(-20.0%) | -$21.01 M(+35.3%) |
| Sept 2015 | - | -$6.85 M(+51.8%) | -$15.53 M(+78.9%) |
| June 2015 | - | -$4.51 M(+8.3%) | -$8.68 M(+108.3%) |
| Mar 2015 | - | -$4.17 M | -$4.17 M |
FAQ
- What is Salarius Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual FCF year-on-year change?
- What is Salarius Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly FCF year-on-year change?
- What is Salarius Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals TTM FCF year-on-year change?
What is Salarius Pharmaceuticals annual free cash flow?
The current annual FCF of SLRX is -$12.85 M
What is the all time high annual FCF for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual free cash flow is -$10.20 M
What is Salarius Pharmaceuticals annual FCF year-on-year change?
Over the past year, SLRX annual free cash flow has changed by +$6.25 M (+32.73%)
What is Salarius Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of SLRX is -$1.36 M
What is the all time high quarterly FCF for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly free cash flow is -$743.00 K
What is Salarius Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, SLRX quarterly free cash flow has changed by +$2.39 M (+63.81%)
What is Salarius Pharmaceuticals TTM free cash flow?
The current TTM FCF of SLRX is -$5.29 M
What is the all time high TTM FCF for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high TTM free cash flow is -$4.17 M
What is Salarius Pharmaceuticals TTM FCF year-on-year change?
Over the past year, SLRX TTM free cash flow has changed by +$10.75 M (+67.01%)